Remote medical platform Veri Medtech (VRHI.US) announced the IPO terms: focusing on the medical cannabis track, issuing a price of $4 per share.

Veri Medtech Holdings (VRHI.US), a provider of remote medical platforms for medical marijuana patients, announced its IPO terms on Thursday. The company is currently trading on the over-the-counter market (OTC) under the ticker symbol "VRHI". Based in McLean, Virginia, the company plans to issue 3.8 million shares at a price of $4 per share, raising $15 million. Veri Medtech offers online and offline consulting services in multiple states. The company operates the Veriheal platform, which has approved over 400,000 patients and holds a market share of approximately 5%; in addition, it also operates the DosePop platform, focusing on direct-to-consumer digital health services in areas such as weight loss, ADHD, dermatology, anti-aging, and sexual health. Established in 2017, Veri Medtech Holdings generated revenue of $11 million in the 12 months leading up to December 31, 2025. The company plans to list on the Nasdaq under the ticker symbol "VRHI", with Network 1 Financial Securities serving as the exclusive bookrunner for the transaction.